748 related articles for article (PubMed ID: 18725692)
21. Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration.
Venugopal JR; Low S; Choon AT; Kumar AB; Ramakrishna S
Artif Organs; 2008 May; 32(5):388-97. PubMed ID: 18471168
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro.
Shor L; Güçeri S; Wen X; Gandhi M; Sun W
Biomaterials; 2007 Dec; 28(35):5291-7. PubMed ID: 17884162
[TBL] [Abstract][Full Text] [Related]
23. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration.
Patlolla A; Collins G; Arinzeh TL
Acta Biomater; 2010 Jan; 6(1):90-101. PubMed ID: 19631769
[TBL] [Abstract][Full Text] [Related]
24. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering.
Chang KY; Hung LH; Chu IM; Ko CS; Lee YD
J Biomed Mater Res A; 2010 Feb; 92(2):712-23. PubMed ID: 19274722
[TBL] [Abstract][Full Text] [Related]
25. Gravity spun polycaprolactone fibres for soft tissue engineering: interaction with fibroblasts and myoblasts in cell culture.
Williamson MR; Adams EF; Coombes AG
Biomaterials; 2006 Mar; 27(7):1019-26. PubMed ID: 16054685
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method.
Oh SH; Park IK; Kim JM; Lee JH
Biomaterials; 2007 Mar; 28(9):1664-71. PubMed ID: 17196648
[TBL] [Abstract][Full Text] [Related]
27. Porous alginate/poly(ε-caprolactone) scaffolds: preparation, characterization and in vitro biological activity.
Grandi C; Di Liddo R; Paganin P; Lora S; Dalzoppo D; Feltrin G; Giraudo C; Tommasini M; Conconi MT; Parnigotto PP
Int J Mol Med; 2011 Mar; 27(3):455-67. PubMed ID: 21206967
[TBL] [Abstract][Full Text] [Related]
28. Polycaprolactone/hydroxyapatite composite scaffolds: preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells.
Chuenjitkuntaworn B; Inrung W; Damrongsri D; Mekaapiruk K; Supaphol P; Pavasant P
J Biomed Mater Res A; 2010 Jul; 94(1):241-51. PubMed ID: 20166220
[TBL] [Abstract][Full Text] [Related]
29. Multiscale three-dimensional scaffolds for soft tissue engineering via multimodal electrospinning.
Soliman S; Pagliari S; Rinaldi A; Forte G; Fiaccavento R; Pagliari F; Franzese O; Minieri M; Di Nardo P; Licoccia S; Traversa E
Acta Biomater; 2010 Apr; 6(4):1227-37. PubMed ID: 19887125
[TBL] [Abstract][Full Text] [Related]
30. Precision extruding deposition (PED) fabrication of polycaprolactone (PCL) scaffolds for bone tissue engineering.
Shor L; Güçeri S; Chang R; Gordon J; Kang Q; Hartsock L; An Y; Sun W
Biofabrication; 2009 Mar; 1(1):015003. PubMed ID: 20811098
[TBL] [Abstract][Full Text] [Related]
31. Surface modification of nanofibrous polycaprolactone/gelatin composite scaffold by collagen type I grafting for skin tissue engineering.
Gautam S; Chou CF; Dinda AK; Potdar PD; Mishra NC
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():402-9. PubMed ID: 24268275
[TBL] [Abstract][Full Text] [Related]
32. The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds.
Lee SJ; Oh SH; Liu J; Soker S; Atala A; Yoo JJ
Biomaterials; 2008 Apr; 29(10):1422-30. PubMed ID: 18096219
[TBL] [Abstract][Full Text] [Related]
33. Biomineralized porous composite scaffolds prepared by chemical synthesis for bone tissue regeneration.
Raucci MG; D'Antò V; Guarino V; Sardella E; Zeppetelli S; Favia P; Ambrosio L
Acta Biomater; 2010 Oct; 6(10):4090-9. PubMed ID: 20417736
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and cytocompatibility study of poly (epsilon-caprolactone)/silk sericin nanofibrous scaffolds].
Li H; Li L; Qian Y; Cai K; Lu Y; Zhong L; Liu W; Yang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):305-9. PubMed ID: 21604491
[TBL] [Abstract][Full Text] [Related]
35. In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone).
Seyednejad H; Gawlitta D; Kuiper RV; de Bruin A; van Nostrum CF; Vermonden T; Dhert WJ; Hennink WE
Biomaterials; 2012 Jun; 33(17):4309-18. PubMed ID: 22436798
[TBL] [Abstract][Full Text] [Related]
36. Macroporous hydroxyapatite scaffolds for bone tissue engineering applications: physicochemical characterization and assessment of rat bone marrow stromal cell viability.
Oliveira JM; Silva SS; Malafaya PB; Rodrigues MT; Kotobuki N; Hirose M; Gomes ME; Mano JF; Ohgushi H; Reis RL
J Biomed Mater Res A; 2009 Oct; 91(1):175-86. PubMed ID: 18780358
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
[TBL] [Abstract][Full Text] [Related]
38. A co-cultured skin model based on cell support membranes.
Dai NT; Yeh MK; Liu DD; Adams EF; Chiang CH; Yen CY; Shih CM; Sytwu HK; Chen TM; Wang HJ; Williamson MR; Coombes AG
Biochem Biophys Res Commun; 2005 Apr; 329(3):905-8. PubMed ID: 15752741
[TBL] [Abstract][Full Text] [Related]
39. Fabrication of porous polycaprolactone/hydroxyapatite (PCL/HA) blend scaffolds using a 3D plotting system for bone tissue engineering.
Park SA; Lee SH; Kim WD
Bioprocess Biosyst Eng; 2011 May; 34(4):505-13. PubMed ID: 21170553
[TBL] [Abstract][Full Text] [Related]
40. Fabricating microparticles/nanofibers composite and nanofiber scaffold with controllable pore size by rotating multichannel electrospinning.
Huang YY; Wang DY; Chang LL; Yang YC
J Biomater Sci Polym Ed; 2010; 21(11):1503-14. PubMed ID: 20534198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
